Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose

• Sholukh AM,
• Siddappa NB,
• Shanmuganathan V,
• Lakhashe SK,
• Rasmussen RA,
• Watkins JD,
• Vyas HK,
• Mukhtar MM,
• Hemashettar G,
• Thorat S,
• Yoon JK,
• Villinger F,
• Novembre FJ,
• Landucci G,
• Forthal DN,
• Ratcliffe S,
• Robert-Guroff M,
• Polonis V,
• Montefiori DC,
• Ertl HC,
• Ruprecht RM

Affiliations

Sholukh AM

Siddappa NB

Shanmuganathan V

Lakhashe SK

Rasmussen RA

Watkins JD

Vyas HK

Mukhtar MM

Hemashettar G

Thorat S

Yoon JK

Villinger F

Novembre FJ

Landucci G

Forthal DN

Ratcliffe S

Robert-Guroff M

Polonis V

Montefiori DC

Ertl HC

Ruprecht RM